Share Your Feedback
Asimov
Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.
Funding
Growth Stage
Current Stage
$175M
Recent Funding
$205M
Total Funding
Leadership Team
Alec Nielsen
Founder & CEO
Christopher Voigt
Co-FounderRecent News
